Consumer Genomics Market Size, Share & Trends Analysis Report By Application (Genetic Relatedness, Ancestry, Diagnostics, Sports Nutrition & Health), By Region (North America, Europe), And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Consumer Genomics Market: Methodology and Scope
                    1.1. Market Segment & Scope
                        1.1.1. Application
                        1.1.2. Regional Scope
                        1.1.3. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                    1.4. Information Or Data Analysis
                        1.4.1. Data Analysis Model
                    1.5. Market Scope & Segment Definition
                    1.6. Market Model
                        1.6.1. Market Study, By Company Market Share
                        1.6.2. Regional Analysis
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
                        1.9.1. Objective 1
                        1.9.2. Objective 2
Chapter 2. Consumer Genomics Market: Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Consumer Genomics Market: Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Rise in interest of consumers & physicians in DTC kits & consequent rise in sales of DNA test kits
                            3.2.1.2. Increase in access to DTC services due to reducing cost of genotyping
                            3.2.1.3. Expansion in applications of DTC genetics
                                3.2.1.3.1. Health testing
                                3.2.1.3.2. Ancestry
                                3.2.1.3.3. Genetic relatedness
                            3.2.1.4. Significant investments & initiatives by companies to maintain their competitive edge in the market
                            3.2.1.5. Growing trend of personalized genomics
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Ethical and clinical issues pertaining to the use of DTC products & personalized treatment
                            3.2.2.2. Misleading results create challenges in adoption of home-based genetic tests
                            3.2.2.3. Regulatory challenges pertaining to the use of DTC genetic tests
                    3.3. Industry Analysis Tools
                        3.3.1. Porter’s Five Forces Analysis
                        3.3.2. PESTEL Analysis
                        3.3.3. COVID-19 Impact Analysis
Chapter 4. Consumer Genomics Application Business Analysis
                    4.1. Consumer Genomics Market: Application Movement Analysis
                    4.2. Genetic Relatedness
                        4.2.1. Genetic Relatedness Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.3. Ancestry
                        4.3.1. Ancestry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.4. Lifestyle, Wellness, & Nutrition
                        4.4.1. Lifestyle, Wellness, & Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.5. Diagnostics
                        4.5.1. Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.6. Sports Nutrition & Health
                        4.6.1. Sports Nutrition & Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.7. Reproductive Health
                        4.7.1. Reproductive Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.8. Personalized medicine & Pharmacogenetic testing
                        4.8.1. Personalized medicine & Pharmacogenetic testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.9. Others
                        4.9.1. Other Application Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Regional Business Analysis
                    5.1. Consumer Genomics Market: Regional Market Snapshot
                    5.2. North America
                        5.2.1. North America Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.2.2. U.S.
                            5.2.2.1. Key Country Dynamics
                            5.2.2.2. Target Disease Prevalence
                            5.2.2.3. Competitive Scenario
                            5.2.2.4. Regulatory Framework
                            5.2.2.5. U.S. Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.2.3. Canada
                            5.2.3.1. Key Country Dynamics
                            5.2.3.2. Target Disease Prevalence
                            5.2.3.3. Competitive Scenario
                            5.2.3.4. Regulatory Framework
                            5.2.3.5. Canada Consumer Genomics Market, 2018 - 2030 (USD Million)
                    5.3. Europe
                        5.3.1. Europe Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.3.2. UK
                            5.3.2.1. Key Country Dynamics
                            5.3.2.2. Target Disease Prevalence
                            5.3.2.3. Competitive Scenario
                            5.3.2.4. Regulatory Framework
                            5.3.2.5. UK Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.3.3. Germany
                            5.3.3.1. Key Country Dynamics
                            5.3.3.2. Target Disease Prevalence
                            5.3.3.3. Competitive Scenario
                            5.3.3.4. Regulatory Framework
                            5.3.3.5. Germany Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.3.4. France
                            5.3.4.1. Key Country Dynamics
                            5.3.4.2. Target Disease Prevalence
                            5.3.4.3. Competitive Scenario
                            5.3.4.4. Regulatory Framework
                            5.3.4.5. France Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.3.5. Italy
                            5.3.5.1. Key Country Dynamics
                            5.3.5.2. Target Disease Prevalence
                            5.3.5.3. Competitive Scenario
                            5.3.5.4. Regulatory Framework
                            5.3.5.5. Italy Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.3.6. Spain
                            5.3.6.1. Key Country Dynamics
                            5.3.6.2. Target Disease Prevalence
                            5.3.6.3. Competitive Scenario
                            5.3.6.4. Regulatory Framework
                            5.3.6.5. Spain Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.3.7. Denmark
                            5.3.7.1. Key Country Dynamics
                            5.3.7.2. Target Disease Prevalence
                            5.3.7.3. Competitive Scenario
                            5.3.7.4. Regulatory Framework
                            5.3.7.5. Denmark Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.3.8. Sweden
                            5.3.8.1. Key Country Dynamics
                            5.3.8.2. Target Disease Prevalence
                            5.3.8.3. Competitive Scenario
                            5.3.8.4. Regulatory Framework
                            5.3.8.5. Sweden Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.3.9. Norway
                            5.3.9.1. Key Country Dynamics
                            5.3.9.2. Target Disease Prevalence
                            5.3.9.3. Competitive Scenario
                            5.3.9.4. Regulatory Framework
                            5.3.9.5. Norway Consumer Genomics Market, 2018 - 2030 (USD Million)
                    5.4. Asia Pacific
                        5.4.1. Asia Pacific Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.4.2. Japan
                            5.4.2.1. Key Country Dynamics
                            5.4.2.2. Target Disease Prevalence
                            5.4.2.3. Competitive Scenario
                            5.4.2.4. Regulatory Framework
                            5.4.2.5. Japan Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.4.3. China
                            5.4.3.1. Key Country Dynamics
                            5.4.3.2. Target Disease Prevalence
                            5.4.3.3. Competitive Scenario
                            5.4.3.4. Regulatory Framework
                            5.4.3.5. China Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.4.4. India
                            5.4.4.1. Key Country Dynamics
                            5.4.4.2. Target Disease Prevalence
                            5.4.4.3. Competitive Scenario
                            5.4.4.4. Regulatory Framework
                            5.4.4.5. India Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.4.5. Australia
                            5.4.5.1. Key Country Dynamics
                            5.4.5.2. Target Disease Prevalence
                            5.4.5.3. Competitive Scenario
                            5.4.5.4. Regulatory Framework
                            5.4.5.5. Australia Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.4.6. Switzerland
                            5.4.6.1. Key Country Dynamics
                            5.4.6.2. Target Disease Prevalence
                            5.4.6.3. Competitive Scenario
                            5.4.6.4. Regulatory Framework
                            5.4.6.5. Switzerland Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.4.7. Thailand
                            5.4.7.1. Key Country Dynamics
                            5.4.7.2. Target Disease Prevalence
                            5.4.7.3. Competitive Scenario
                            5.4.7.4. Regulatory Framework
                            5.4.7.5. Thailand Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.4.8. South Korea
                            5.4.8.1. Key Country Dynamics
                            5.4.8.2. Target Disease Prevalence
                            5.4.8.3. Competitive Scenario
                            5.4.8.4. Regulatory Framework
                            5.4.8.5. South Korea Consumer Genomics Market, 2018 - 2030 (USD Million)
                    5.5. Latin America
                        5.5.1. Latin America Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.5.2. Brazil
                            5.5.2.1. Key Country Dynamics
                            5.5.2.2. Target Disease Prevalence
                            5.5.2.3. Competitive Scenario
                            5.5.2.4. Regulatory Framework
                            5.5.2.5. Brazil Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.5.3. Mexico
                            5.5.3.1. Key Country Dynamics
                            5.5.3.2. Target Disease Prevalence
                            5.5.3.3. Competitive Scenario
                            5.5.3.4. Regulatory Framework
                            5.5.3.5. Mexico Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.5.4. Argentina
                            5.5.4.1. Key Country Dynamics
                            5.5.4.2. Target Disease Prevalence
                            5.5.4.3. Competitive Scenario
                            5.5.4.4. Regulatory Framework
                            5.5.4.5. Argentina Consumer Genomics Market, 2018 - 2030 (USD Million)
                    5.6. MEA
                        5.6.1. MEA Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.6.2. South Africa
                            5.6.2.1. Key Country Dynamics
                            5.6.2.2. Target Disease Prevalence
                            5.6.2.3. Competitive Scenario
                            5.6.2.4. Regulatory Framework
                            5.6.2.5. South Africa Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.6.3. Saudi Arabia
                            5.6.3.1. Key Country Dynamics
                            5.6.3.2. Target Disease Prevalence
                            5.6.3.3. Competitive Scenario
                            5.6.3.4. Regulatory Framework
                            5.6.3.5. Saudi Arabia Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.6.4. UAE
                            5.6.4.1. Key Country Dynamics
                            5.6.4.2. Target Disease Prevalence
                            5.6.4.3. Competitive Scenario
                            5.6.4.4. Regulatory Framework
                            5.6.4.5. UAE Consumer Genomics Market, 2018 - 2030 (USD Million)
                        5.6.5. Kuwait
                            5.6.5.1. Key Country Dynamics
                            5.6.5.2. Target Disease Prevalence
                            5.6.5.3. Competitive Scenario
                            5.6.5.4. Regulatory Framework
                            5.6.5.5. Kuwait Consumer Genomics Market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Company Categorization
                    6.2. Strategy Mapping
                    6.3. Company Market Share Analysis, 2022
                    6.4. Company Profiles/Listing
                        6.4.1. Ancestry
                            6.4.1.1. Overview
                            6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.1.3. Product Benchmarking
                            6.4.1.4. Strategic Initiatives
                        6.4.2. 23andMe, Inc.
                            6.4.2.1. Overview
                            6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.2.3. Product Benchmarking
                            6.4.2.4. Strategic Initiatives
                        6.4.3. Gene by Gene, Ltd.
                            6.4.3.1. Overview
                            6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.3.3. Product Benchmarking
                            6.4.3.4. Strategic Initiatives
                        6.4.4. Mapmygenome
                            6.4.4.1. Overview
                            6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.4.3. Product Benchmarking
                            6.4.4.4. Strategic Initiatives
                        6.4.5. Color Health, Inc.
                            6.4.5.1. Overview
                            6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.5.3. Product Benchmarking
                            6.4.5.4. Strategic Initiatives
                        6.4.6. Positive Biosciences, Ltd.
                            6.4.6.1. Overview
                            6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.6.3. Product Benchmarking
                            6.4.6.4. Strategic Initiatives
                        6.4.7. Futura Genetics
                            6.4.7.1. Overview
                            6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.7.3. Product Benchmarking
                            6.4.7.4. Strategic Initiatives
                        6.4.8. Helix OpCo LLC
                            6.4.8.1. Overview
                            6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.8.3. Product Benchmarking
                            6.4.8.4. Strategic Initiatives
                        6.4.9. MyHeritage Ltd.
                            6.4.9.1. Overview
                            6.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.9.3. Product Benchmarking
                            6.4.9.4. Strategic Initiatives
                        6.4.10. Pathway Genomics
                            6.4.10.1. Overview
                            6.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.10.3. Product Benchmarking
                            6.4.10.4. Strategic Initiatives
                        6.4.11. Veritas
                            6.4.11.1. Overview
                            6.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.11.3. Product Benchmarking
                            6.4.11.4. Strategic Initiatives
                        6.4.12. Myriad Genetics, Inc.
                            6.4.12.1. Overview
                            6.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.12.3. Product Benchmarking
                            6.4.12.4. Strategic Initiatives
                        6.4.13. Illumina, Inc.
                            6.4.13.1. Overview
                            6.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.13.3. Product Benchmarking
                            6.4.13.4. Strategic Initiatives
                        6.4.14. Amgen, Inc.
                            6.4.14.1. Overview
                            6.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.14.3. Product Benchmarking
                            6.4.14.4. Strategic Initiatives
                        6.4.15. Xcode Life
                            6.4.15.1. Overview
                            6.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.15.3. Product Benchmarking
                            6.4.15.4. Strategic Initiatives
                        6.4.16. Diagnomics, Inc.
                            6.4.16.1. Overview
                            6.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.16.3. Product Benchmarking
                            6.4.16.4. Strategic Initiatives
                        6.4.17. Toolbox Genomics
                            6.4.17.1. Overview
                            6.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.17.3. Product Benchmarking
                            6.4.17.4. Strategic Initiatives

List of Tables

Table 1 List of abbreviations
Table 2 List of abbreviation
Table 3 Global consumer genomics market, by region, 2018 - 2030 (USD Million)
Table 4 North America consumer genomics market, by country, 2018 - 2030 (USD Million)
Table 5 North America consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 7 Canada consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 8 Europe consumer genomics market, by country, 2018 - 2030 (USD Million)
Table 9 Europe consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 10 UK consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 11 Germany consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 12 France consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 13 Italy consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 14 Spain consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 15 Denmark consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 16 Sweden consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 17 Norway consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 18 Asia Pacific consumer genomics market, by country, 2018 - 2030 (USD Million)
Table 19 Asia Pacific consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 20 Japan consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 21 China consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 22 India consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 23 Australia consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 24 Switzerland consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 25 Thailand consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 26 South Korea consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 27 Latin America consumer genomics market, by country, 2018 - 2030 (USD Million)
Table 28 Latin America consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 29 Brazil consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 30 Mexico consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 31 Argentina consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 32 Middle East & Africa consumer genomics market, by country, 2018 - 2030 (USD Million)
Table 33 Middle East & Africa consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 34 South Africa consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 35 Saudi Arabia consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 36 UAE consumer genomics market, by application, 2018 - 2030 (USD Million)
Table 37 Kuwait consumer genomics market, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Consumer Genomics market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 Global Consumer Genomics market: Application movement analysis
Fig. 15 Global Consumer Genomics market, for genetic relatedness, 2018 - 2030 (USD Million)
Fig. 16 Global Consumer Genomics market, for ancestry, 2018 - 2030 (USD Million)
Fig. 17 Global Consumer Genomics market, for lifestyle, wellness, & nutrition, 2018 - 2030 (USD Million)
Fig. 18 Global Consumer Genomics market, for diagnostics, 2018 - 2030 (USD Million)
Fig. 19 Global Consumer Genomics market, for sports nutrition & health, 2018 - 2030 (USD Million)
Fig. 20 Global Consumer Genomics market, for reproductive health, 2018 - 2030 (USD Million)
Fig. 21 Global Consumer Genomics market, for personalized medicine & pharmacogenetic testing, 2018 - 2030 (USD Million)
Fig. 22 Global Consumer Genomics market, for other applications, 2018 - 2030 (USD Million)
Fig. 23 Regional marketplace: Key takeaways
Fig. 24 Regional outlook, 2022 & 2030
Fig. 25 Global Consumer Genomics market: Region movement analysis
Fig. 26 North America Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 27 U.S. Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 28 Canada Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 29 Europe Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 30 Germany Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 31 UK Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 32 France Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 33 Italy Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 34 Spain Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 35 Denmark Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 36 Sweden Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 37 Norway Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 38 Asia Pacific Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 39 Japan Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 40 China Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 41 India Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 42 Australia Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 43 Switzerland Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 44 South Korea Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 45 Thailand Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 46 Latin America Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 47 Brazil Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 48 Mexico Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 49 Argentina Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 50 Middle East and Africa Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 51 South Africa Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 52 Saudi Arabia Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 53 UAE Consumer Genomics market, 2018 - 2030 (USD Million)
Fig. 54 Kuwait Consumer Genomics market, 2018 - 2030 (USD Million)